|
CAMTA1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.431400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.032200E-01 |
| Normal-vs-Stage2 |
5.472400E-02 |
| Normal-vs-Stage3 |
6.691000E-01 |
| Normal-vs-Stage4 |
2.646800E-01 |
| Stage1-vs-Stage2 |
5.063800E-02 |
| Stage1-vs-Stage3 |
2.757000E-01 |
| Stage1-vs-Stage4 |
3.410800E-01 |
| Stage2-vs-Stage3 |
1.424190E-02 |
| Stage2-vs-Stage4 |
3.920000E-01 |
| Stage3-vs-Stage4 |
1.094190E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.109000E-01 |
| Normal-vs-AfricanAmerican |
7.065000E-01 |
| Normal-vs-Asian |
3.117400E-01 |
| Caucasian-vs-AfricanAmerican |
4.338200E-01 |
| Caucasian-vs-Asian |
4.685000E-01 |
| AfricanAmerican-vs-Asian |
2.509400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.004800E-01 |
| Normal-vs-Female |
4.102400E-01 |
| Male-vs-Female |
5.286300E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.622000E-01 |
| Normal-vs-Age(41-60Yrs) |
7.260200E-01 |
| Normal-vs-Age(61-80Yrs) |
1.841400E-01 |
| Normal-vs-Age(81-100Yrs) |
2.619200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.537200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.828570E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.202600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.857800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.074200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.706300E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.965600E-01 |
| Classical-VS-Follicular |
9.338600E-01 |
| Classical-VS-Other |
2.650200E-01 |
| Classical-VS-Normal |
5.878800E-01 |
| Tall-VS-Follicular |
8.858200E-01 |
| Tall-VS-Other |
3.371200E-01 |
| Tall-VS-Normal |
6.485600E-01 |
| Follicular-VS-Other |
4.042200E-01 |
| Follicular-VS-Normal |
7.172000E-01 |
| Other-VS-Normal |
3.933400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.266800E-01 |
| Normal-vs-N1 |
9.587000E-01 |
| N0-vs-N1 |
5.634000E-01 |
|
|
